Brief: Immucell Announces Unaudited Financial Results For The First Quarter Ended March 31, 2021
May 13 (Reuters) - ImmuCell Corp ICCC.O :
* IMMUCELL ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE
FIRST
QUARTER ENDED MARCH 31, 2021
* IMMUCELL CORP QTRLY PRODUCT SALES $4.1 MILLION VERSUS $4.9
MILLION
* IMMUCELL CORP LOSS PER SHARE $0.06
Source text for Eikon: ID:nGNX1TBNKw
Further company coverage: ICCC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ImmuCell
See all newsBrief: Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results
ImmuCell Q2 revenue rises on higher distributor volume, price realization
Brief: ImmuCell Corporation Q2 EPS USD 0.2
ImmuCell Q2 product sales rise 11.5% on strong US demand
ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year